Navigation Links
VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
Date:8/6/2019

VetStem Biopharma has long been a leader in veterinary stem cell manufacturing with clinical, regulatory and GMP manufacturing experience. In November it spun out a human regenerative medicine subsidiary, Personalized Stem Cells, Inc. (PSC). With extensive regulatory experience and one of the first cGMP cell manufacturing facilities in California, VetStem signed a contract for regulatory advisement, clinical trial management, and manufacturing of stem cells for use in PSC’s Phase I and Phase II FDA human studies. VetStem’s cGMP cleanroom facility has been inspected by the FDA and is licensed by the California Department of Public Health for human drug manufacturing.

Based on their vast experience and the use of their FDA master files and database of veterinary stem cell therapy, VetStem made the application to FDA on behalf of PSC to secure FDA approval of a human IND for stem cell therapy in patients with osteoarthritis. This FDA-IND approval to conduct clinical trials came a mere eight months after the founding of PSC and demonstrates that the use of real-world veterinary data can accelerate development. VetStem has data on over 17,000 veterinary stem cell patients and has GCP, GMP, and GLP experience.

“The rapid approval of PSC’s first IND was only possible by leveraging the experience and resources of VetStem. Our plans for expanding the scope of our clinical trials can only be accomplished with a responsive and experienced CRO/CMO” said Michael Dale, CEO of Personalized Stem Cells.

VetStem CEO, Dr. Robert Harman, stated, “PSC is a private company built on science and research and we are honored to be their regulatory and clinical CRO for their FDA trials and to manufacture their cell therapy products. This again demonstrates the close link between human and veterinary medicine and how together we can more rapidly advance the development of essential new cellular drugs. Our growth in human cell therapy contract manufacturing continues with this key contract. VetStem offers IND development services to human biopharma companies in the cell therapy field.”

About VetStem Biopharma, Inc.
VetStem Biopharma was formed in 2002 to advance regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), currently offers veterinarians an autologous stem cell processing service (from patients’ own fat tissue) among other regenerative modalities. With a unique expertise acquired over the past 15 years and 17,000 patients treated by veterinarians for joint, tendon or ligament issues, VetStem has made regenerative medicine applications a therapeutic reality beyond the realm of research. The Company’s stated mission being “to extend and enhance the lives of animals by improving the quality of recovery in acute conditions, but also by unlocking ways to slow, stop and ultimately revert the course of chronic diseases”. In addition to its’ own portfolio of patents, VetStem holds exclusive global licenses to a portfolio of issued patents in the field of regenerative medicine.

About Personalized Stem Cells, Inc.
Personalized Stem Cells was formed in 2018 to advance and legitimize human regenerative medicine. This privately held biopharmaceutical enterprise, based near San Diego (California), offers qualified physicians who enroll, an FDA compliant autologous stem cell product (from patient’s own fat tissue) for use in FDA approved clinical trials. PSC is driving development and adoption of stem cell and regenerative medicine within the FDA-IND process by providing quality manufactured, safety tested cells, and well-defined clinical trials. PSC has licensed a portfolio of over 70 issued patents in the field of regenerative medicine.

Read the full story at https://www.prweb.com/releases/vetstem_biopharma_secures_fda_approval_of_first_human_ind_for_its_subsidiary_personalized_stem_cells_inc/prweb16485218.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. VetStem Biopharma is Pleased to Share the Success Story of Mandy, who was Treated with Stem Cell Therapy by Dr. Jerrold Bausman at VCA Vet Specialists of the Valley
2. Labrador Retriever Gets Back to Playing Fetch After Receiving VetStem Regenerative Stem Cell Therapy
3. VetStem Biopharma is Pleased to Share the Success Story of Sam Who was Treated with Stem Cell Therapy by Dr. Lucy Roberts at Animal Medical Center of Tuscaloosa
4. VetStem Biopharma is Pleased to Share the Success Story of Jack, a Great Pyrenees who was Treated with Stem Cell Therapy by Dr. Andrea Hayes
5. VetStem Biopharma Shares the Story of Anthony Who Came Back to Win Division Championship After Being Treated with Stem Cell Therapy by Dr. Ruth-Anne Richter
6. VetStem Biopharma Shares the Story of a Champion Horse Who Continues to Win After a Successful Stem Cell Treatment by Dr. John McCarroll
7. VetStem Biopharma is Pleased to Share the Success Story of Ava who was Treated with VetStem Cell Therapy by Dr. David Luck
8. VetStem Biopharma Shares the Success Story of Harper who was Treated with VetStem Cell Therapy by Dr. Christopher Eich
9. VetStem Biopharma Shares the Success Story of Seve who was Treated with VetStem Cell Therapy by Dr. Cindy Echevarria
10. VetStem Biopharma Enters Pet Cancer Field with Key License from Leading Human Cancer Company, Calidi Biotherapeutics
11. Alios BioPharma initiates Phase 1 clinical trial for respiratory syncytial virus infection
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2019)... ... 09, 2019 , ... Cardea is excited to announce the ... Cardea first broke the news of the proposed merger in September, along ... with CRISPR-Chip technology, the Genome Sensor is the world’s first DNA search engine. ...
(Date:10/10/2019)... ... October 10, 2019 , ... ... and ultrasound, invites attendees of the American Society of Anesthesiologists 2019 Annual Meeting ... place on October 19-21 in Orlando, Florida, and will provide more than 14,000 ...
(Date:10/8/2019)... , ... October 08, 2019 , ... ... announced new apps that make it easier than ever for businesses and organizations ... The new Countdown App enables organizations to count down to or count up ...
Breaking Biology News(10 mins):
(Date:10/3/2019)... (PRWEB) , ... October 02, 2019 , ... ... using mass spectrometry, is pleased to announce that it has moved into a ... among other analytical instruments, the new facility demonstrates the company's continuous commitment to ...
(Date:9/24/2019)... and WALTHAM, Mass. (PRWEB) , ... ... ... the leading global provider of advanced delivery technologies, development, and manufacturing solutions ... Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of ...
(Date:9/17/2019)... (PRWEB) , ... September 17, 2019 , ... ... that Julie Delaney, Director, Project and Clinical Supplies Management, Asia Pacific (APAC) will ... One Farrer Hotel, Singapore, on Sept. 25-26, 2019. , On Thursday, Sept. 26, ...
(Date:9/17/2019)... (PRWEB) , ... September 16, 2019 , ... ... Nationwide via CNBC on Saturday, September 21st @11:00am ET. Check local listings for ... Pte. Ltd. (Credo Biomedical), a molecular diagnostic company from Singapore dedicated to ...
Breaking Biology Technology: